Literature DB >> 20484733

Deletion of immunoproteasome subunits imprints on the transcriptome and has a broad impact on peptides presented by major histocompatibility complex I molecules.

Danielle de Verteuil1, Tara L Muratore-Schroeder, Diana P Granados, Marie-Hélène Fortier, Marie-Pierre Hardy, Alexandre Bramoullé, Etienne Caron, Krystel Vincent, Sylvie Mader, Sébastien Lemieux, Pierre Thibault, Claude Perreault.   

Abstract

Proteasome-mediated proteolysis plays a crucial role in many basic cellular processes. In addition to constitutive proteasomes (CPs), which are found in all eukaryotes, jawed vertebrates also express immunoproteasomes (IPs). Evidence suggests that the key role of IPs may hinge on their impact on the repertoire of peptides associated to major histocompatibility complex (MHC) I molecules. Using a label-free quantitative proteomics approach, we identified 417 peptides presented by MHC I molecules on primary mouse dendritic cells (DCs). By comparing MHC I-associated peptides (MIPs) eluted from primary DCs and thymocytes, we found that the MIP repertoire concealed a cell type-specific signature correlating with cell function. Notably, mass spectrometry analyses of DCs expressing or not IP subunits MECL1 and LMP7 showed that IPs substantially increase the abundance and diversity of MIPs. Bioinformatic analyses provided evidence that proteasomes harboring LMP7 and MECL1 have specific cleavage preferences and recognize unstructured protein regions. Moreover, while differences in MIP repertoire cannot be attributed to potential effects of IPs on gene transcription, IP subunits deficiency altered mRNA levels of a set of genes controlling DC function. Regulated genes segregated in clusters that were enriched in chromosomes 4 and 8. Our peptidomic studies performed on untransfected primary cells provide a detailed account of the MHC I-associated immune self. This work uncovers the dramatic impact of IP subunits MECL1 and LMP7 on the MIP repertoire and their non-redundant influence on expression of immune-related genes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20484733      PMCID: PMC2938112          DOI: 10.1074/mcp.M900566-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  60 in total

1.  IFN-gamma exposes a cryptic cytotoxic T lymphocyte epitope in HIV-1 reverse transcriptase.

Authors:  A K Sewell; D A Price; H Teisserenc; B L Booth; U Gileadi; F M Flavin; J Trowsdale; R E Phillips; V Cerundolo
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

2.  The subunits MECL-1 and LMP2 are mutually required for incorporation into the 20S proteasome.

Authors:  M Groettrup; S Standera; R Stohwasser; P M Kloetzel
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

3.  A putative stimulatory role for activator turnover in gene expression.

Authors:  J Russell Lipford; Geoffrey T Smith; Yong Chi; Raymond J Deshaies
Journal:  Nature       Date:  2005-11-03       Impact factor: 49.962

4.  The structure and location of SIMP/STT3B account for its prominent imprint on the MHC I immunopeptidome.

Authors:  Etienne Caron; Renée Charbonneau; Gabrielle Huppé; Sylvie Brochu; Claude Perreault
Journal:  Int Immunol       Date:  2005-11-01       Impact factor: 4.823

Review 5.  All the peptides that fit: the beginning, the middle, and the end of the MHC class I antigen-processing pathway.

Authors:  Nilabh Shastri; Sylvain Cardinaud; Susan R Schwab; Thomas Serwold; Jun Kunisawa
Journal:  Immunol Rev       Date:  2005-10       Impact factor: 12.988

Review 6.  The role of chromatin structure in regulating the expression of clustered genes.

Authors:  Duncan Sproul; Nick Gilbert; Wendy A Bickmore
Journal:  Nat Rev Genet       Date:  2005-10       Impact factor: 53.242

7.  IFN-gamma-induced immune adaptation of the proteasome system is an accelerated and transient response.

Authors:  Sylvia Heink; Daniela Ludwig; Peter-M Kloetzel; Elke Krüger
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-08       Impact factor: 11.205

8.  Destructive cleavage of antigenic peptides either by the immunoproteasome or by the standard proteasome results in differential antigen presentation.

Authors:  Jacques Chapiro; Stéphane Claverol; Fanny Piette; Wenbin Ma; Vincent Stroobant; Benoît Guillaume; Jean-Edouard Gairin; Sandra Morel; Odile Burlet-Schiltz; Bernard Monsarrat; Thierry Boon; Benoît J Van den Eynde
Journal:  J Immunol       Date:  2006-01-15       Impact factor: 5.422

9.  The aminopeptidase ERAAP shapes the peptide repertoire displayed by major histocompatibility complex class I molecules.

Authors:  Gianna Elena Hammer; Federico Gonzalez; Marine Champsaur; Dragana Cado; Nilabh Shastri
Journal:  Nat Immunol       Date:  2005-11-20       Impact factor: 25.606

10.  WebGestalt: an integrated system for exploring gene sets in various biological contexts.

Authors:  Bing Zhang; Stefan Kirov; Jay Snoddy
Journal:  Nucleic Acids Res       Date:  2005-07-01       Impact factor: 16.971

View more
  35 in total

Review 1.  DRiPs solidify: progress in understanding endogenous MHC class I antigen processing.

Authors:  Jonathan W Yewdell
Journal:  Trends Immunol       Date:  2011-09-29       Impact factor: 16.687

Review 2.  Immunoproteasomes: structure, function, and antigen presentation.

Authors:  Deborah A Ferrington; Dale S Gregerson
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

3.  Immunoproteasome deficiency is a feature of non-small cell lung cancer with a mesenchymal phenotype and is associated with a poor outcome.

Authors:  Satyendra C Tripathi; Haley L Peters; Ayumu Taguchi; Hiroyuki Katayama; Hong Wang; Amin Momin; Mohit Kumar Jolly; Muge Celiktas; Jaime Rodriguez-Canales; Hui Liu; Carmen Behrens; Ignacio I Wistuba; Eshel Ben-Jacob; Herbert Levine; Jeffrey J Molldrem; Samir M Hanash; Edwin J Ostrin
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-29       Impact factor: 11.205

4.  Human Leukocyte Antigen (HLA) Peptides Derived from Tumor Antigens Induced by Inhibition of DNA Methylation for Development of Drug-facilitated Immunotherapy.

Authors:  Bracha Shraibman; Dganit Melamed Kadosh; Eilon Barnea; Arie Admon
Journal:  Mol Cell Proteomics       Date:  2016-07-13       Impact factor: 5.911

Review 5.  Exploiting non-canonical translation to identify new targets for T cell-based cancer immunotherapy.

Authors:  Céline M Laumont; Claude Perreault
Journal:  Cell Mol Life Sci       Date:  2017-08-19       Impact factor: 9.261

6.  MHC class I-associated peptides derive from selective regions of the human genome.

Authors:  Hillary Pearson; Tariq Daouda; Diana Paola Granados; Chantal Durette; Eric Bonneil; Mathieu Courcelles; Anja Rodenbrock; Jean-Philippe Laverdure; Caroline Côté; Sylvie Mader; Sébastien Lemieux; Pierre Thibault; Claude Perreault
Journal:  J Clin Invest       Date:  2016-11-14       Impact factor: 14.808

7.  Mass spectrometry analysis and quantitation of peptides presented on the MHC II molecules of mouse spleen dendritic cells.

Authors:  Leonia Bozzacco; Haiqiang Yu; Henry A Zebroski; Jörn Dengjel; Haiteng Deng; Svetlana Mojsov; Ralph M Steinman
Journal:  J Proteome Res       Date:  2011-10-14       Impact factor: 4.466

8.  HLA-DR-presented peptide repertoires derived from human monocyte-derived dendritic cells pulsed with blood coagulation factor VIII.

Authors:  Simon D van Haren; Eszter Herczenik; Anja ten Brinke; Koen Mertens; Jan Voorberg; Alexander B Meijer
Journal:  Mol Cell Proteomics       Date:  2011-04-05       Impact factor: 5.911

9.  ERAAP Shapes the Peptidome Associated with Classical and Nonclassical MHC Class I Molecules.

Authors:  Niranjana A Nagarajan; Danielle A de Verteuil; Dev Sriranganadane; Wafaa Yahyaoui; Pierre Thibault; Claude Perreault; Nilabh Shastri
Journal:  J Immunol       Date:  2016-07-01       Impact factor: 5.422

Review 10.  Analysis of Major Histocompatibility Complex (MHC) Immunopeptidomes Using Mass Spectrometry.

Authors:  Etienne Caron; Daniel J Kowalewski; Ching Chiek Koh; Theo Sturm; Heiko Schuster; Ruedi Aebersold
Journal:  Mol Cell Proteomics       Date:  2015-12       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.